Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Presentation AHA 2016

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Presenter: Michael Gibson

November 15, 2016

News Daily News

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

Shelley Wood

October 19, 2016

News Daily News

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Michael O'Riordan

April 29, 2016

News Industry News

Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA

January 26, 2016

News Daily News

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

August 04, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Daily News

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

August 04, 2015

News Daily News

Meta-Analysis: Off-Pump Approach Increases Mortality Risk in CABG

Caitlin E. Cox

March 22, 2012

News Daily News

PARTNER Cohort A Published: Surgical Candidates Obtain Similar 1-Year Survival with TAVI, Surgery

L.A. McKeown

June 07, 2011

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Daily News

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Jason Kahn

January 23, 2011

Advertisement

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

Meta-Analysis: Off-Pump Approach Increases Mortality Risk in CABG

PARTNER Cohort A Published: Surgical Candidates Obtain Similar 1-Year Survival with TAVI, Surgery

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content